UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<Ingredient xmlns="http://hl7.org/fhir">
<id value="Attentin-10mg-Tablet-SE-AJ-ING"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Ingredient Attentin-10mg-Tablet-SE-AJ-ING</b></p><a name="Attentin-10mg-Tablet-SE-AJ-ING"> </a><a name="hcAttentin-10mg-Tablet-SE-AJ-ING"> </a><a name="hcAttentin-10mg-Tablet-SE-AJ-ING-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Attentin-10mg-Tablet-SE-AJ-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001280-00053180,http://ema.europa.eu/fhir/eurdId#986; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Dexamfetamin är avsett för barn och ungdomar i åldern 6 till 17 år som del av ett omfattande behandlingsprogram mot ADHD (Attention Deficit Hyperactivity Disorder) när svar på tidigare behandling med metylfenidat bedöms vara kliniskt otillräckligt. Ett omfattande behandlingsprogram inkluderar vanligtvis psykologiska, pedagogiska och sociala åtgärder. Diagnos ska ställas enligt aktuella DSM-kriterier eller riktlinjerna i ICD-10 och baseras på en omfattande tvärvetenskaplig bedömning av patienten. Dexamfetamin är inte indicerat för alla barn med ADHD och beslutet att använda dexamfetamin måste grundas på en mycket noggrann bedömning av svårighetsgrad och kronicitet av barnets symptom i förhållande till barnets ålder samt potential för missbruk, felaktig eller avvikande användning. Behandling ska ske under överinseende av specialist på beteendestörningar hos barn- och/eller ungdomar.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = dexamfetamine</a></li><li><a href="ManufacturedItemDefinition-Attentin-10mg-Tablet-SE-AJ-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="Attentin-10mg-Tablet-SE-AJ-APD">Attentin-10mg-Tablet-SE-AJ-APD</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000170328}">Dexamfetamine sulphate BP</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 10 milligram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 Tablet<span style="background: LightGoldenRodYellow"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000088421}">Dexamfetamine</span></td></tr></table><p><b>strength</b>: 7.34 milligram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 Tablet<span style="background: LightGoldenRodYellow"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p></blockquote></blockquote></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Attentin-10mg-Tablet-SE-AJ-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Attentin-10mg-Tablet-SE-AJ-MID"/>
</for>
<for>
<reference value="Attentin-10mg-Tablet-SE-AJ-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000170328"/>
<display value="Dexamfetamine sulphate BP"/>
</coding>
</concept>
</code>
<strength>
<presentationRatio>
<numerator>
<value value="10"/>
<unit value="milligram(s)"/>
<system value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110655"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="Tablet"/>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</presentationRatio>
<referenceStrength>
<substance>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000088421"/>
<display value="Dexamfetamine"/>
</coding>
</concept>
</substance>
<strengthRatio>
<numerator>
<value value="7.34"/>
<unit value="milligram(s)"/>
<system value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110655"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="Tablet"/>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</strengthRatio>
</referenceStrength>
</strength>
</substance>
</Ingredient>